Pharsight

ELIQUIS PATENTS FACING OPPOSITIONS

ELIQUIS facing oppositions at the European Patent Office (EPO)

Patent Number Title Applicants Legal Status Legal Status Date Oppositions Activity Alert
EP3017811B1 Apixaban formulations Revoked Mar 22, 2024
TEVA PHARMACEUTICAL
SANDOZ
HAMM & WITTKOPP
KRKA, NOVO MESTO
ZAKLADY FARMACEUTYCZNE POLPHARMA
GENERICS
ZENTIVA, K.S.
INTAS PHARMACEUTICALS
STADA ARZNEIMITTEL
EP3246021B1 Apixaban formulations Revoked Mar 22, 2024
SANDOZ
KRKA, NOVO MESTO
ZENTIVA
TEVA PHARMACEUTICAL
ZAKLADY FARMACEUTYCZNE POLPHARMA
KUTZENBERGER WOLFF & PARTNER
VON SEEBACH, MALTE
ALFRED E. TIEFENBACHER
WITTKOPP, ALEXANDER
GENERICS
INTAS PHARMACEUTICALS
STADA ARZNEIMITTEL
EP3251660B1 Apixaban formulations Revoked Mar 22, 2024
ZAKLADY FARMACEUTYCZNE POLPHARMA
ZENTIVA
KUTZENBERGER WOLFF & PARTNER
MEDICHEM
TEVA PHARMACEUTICAL
INTAS PHARMACEUTICALS
KRKA, NOVO MESTO
SANDOZ
GENERICS
STADA ARZNEIMITTEL
EP3257500B1 Apixaban formulations Revoked Mar 22, 2024
ZAKLADY FARMACEUTYCZNE POLPHARMA
KUTZENBERGER WOLFF & PARTNER
ZENTIVA
MEDICHEM
TEVA PHARMACEUTICAL
INTAS PHARMACEUTICALS
KRKA, NOVO MESTO
SANDOZ
GENERICS
STADA ARZNEIMITTEL
EP2538925B1 Apixaban formulations Revoked Jul 09, 2021
TEVA PHARMACEUTICAL
PLOUGMANN VINGTOFT
ZAKLADY FARMACEUTYCZNE POLPHARMA
STADA ARZNEIMITTEL
KRKA, NOVO MESTO
GALENICUM HEALTH S.L.
GENERICS
HAMM & WITTKOPP
INTAS PHARMACEUTICALS
LEK PHARMACEUTICALS
ZENTIVA